For instance, cervical cancer (CESC), lung cancer (LUAD), and GC (STAD) with high expression of L3MBTL3 were associated with poorer prognosis, while the opposite was observed in cholangiocellular cancer (CHOL) and kidney cancer (KIRC) (Figure 1C). This evidence concerns the gene L3MBTL3 and cervical carcinoma.